Cefaclor (Ceclor® - Eli Lilly and Company)
Authors:
- H. David BergmanHBH. David Bergman
- Eric A. JacksonEJEric A. Jackson
- Alex A. CardoniACAlex A. Cardoni
- 1 January 1980
- journal article
- Published by SAGE Publications in Drug Intelligence & Clinical Pharmacy
- Vol. 14 (1) , 11-16
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Pharmacokinetics of Cefaclor in Patients with End Stage Renal Disease and During HemodialysisAntimicrobial Agents and Chemotherapy, 1978
- Pharmacological Evaluation of Cefaclor in VolunteersAntimicrobial Agents and Chemotherapy, 1978
- Pharmacokinetics of Cefaclor and Cephalexin: Dosage Nomograms for Impaired Renal FunctionAntimicrobial Agents and Chemotherapy, 1978
- A human pharmacology study of cefaclorJournal of Antimicrobial Chemotherapy, 1978
- Pharmacology of Cefaclor in Normal Volunteers and Patients with Renal FailureAntimicrobial Agents and Chemotherapy, 1978
- Pharmacologic Studies with Cefaclor, a New Oral CephalosporinThe Journal of Clinical Pharmacology, 1978
- Stability and Blood Level Determinations of Cefaclor, a New Oral Cephalosporin AntibioticAntimicrobial Agents and Chemotherapy, 1978
- Pharmacokinetics of Cefaclor in Normal Subjects and Patients with Chronic Renal FailureAntimicrobial Agents and Chemotherapy, 1977
- Standardization of a Preparative Ultracentrifuge Method for Quantitative Determination of Protein Binding of Seven AntibioticsThe Journal of Infectious Diseases, 1977
- Comparative Pharmacology of Cefaclor and CephalexinAntimicrobial Agents and Chemotherapy, 1977